1. Home
  2. CTS vs ATRC Comparison

CTS vs ATRC Comparison

Compare CTS & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTS Corporation

CTS

CTS Corporation

HOLD

Current Price

$59.13

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$27.63

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTS
ATRC
Founded
1896
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
CTS
ATRC
Price
$59.13
$27.63
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$51.17
AVG Volume (30 Days)
215.5K
787.4K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.29%
N/A
EPS Growth
15.87
74.74
EPS
0.59
N/A
Revenue
$541,318,000.00
$201,630,000.00
Revenue This Year
$5.55
$15.27
Revenue Next Year
$5.00
$12.21
P/E Ratio
$101.42
N/A
Revenue Growth
4.95
15.40
52 Week Low
$36.03
$26.62
52 Week High
$60.82
$43.18

Technical Indicators

Market Signals
Indicator
CTS
ATRC
Relative Strength Index (RSI) 67.96 43.05
Support Level $41.09 $27.68
Resistance Level $59.66 $30.75
Average True Range (ATR) 2.11 1.57
MACD 0.29 0.04
Stochastic Oscillator 79.12 32.58

Price Performance

Historical Comparison
CTS
ATRC

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: